The impact of the global COVID-19 pandemic on the conduct of clinical trials: Return to normalcy by considering the practical impact of a structured ethical analysis.

British Journal of Clinical Pharmacology
Maurits F J M VissersGeert Jan Groeneveld

Abstract

During the outbreak of the COVID-19 pandemic many clinical trials were abruptly halted. Measures to contain the pandemic are currently taking effect and societies in general and healthcare systems in particular are considering how to return to normalcy. This opens up the discussion when and how clinical trials should be restarted while the COVID-19 pandemic has not yet resolved, and what should happen in case of a resurgence of the virus in the coming months. This article uses the four ethical principles framework as a structured approach to come to a set of practical, ethically grounded guidelines for halting and relaunching clinical trials during the COVID-19 pandemic. The framework applied provides a structured approach for all clinical trials stakeholders and thereby prevents unclear reasoning in a complex situation. While it is essential to prevent the virus from resurging and focus on developing a COVID-19 treatment as soon as possible, it is just as important to our society that we continue developing new drugs for other conditions. In this article we argue that the situation for clinical trials is not essentially different from the pre-COVID-19 era and that an overcautious approach will have negative consequences.

References

May 1, 1977·Clinical Pharmacology and Therapeutics·M HassarL Lasagna
Jul 16, 1994·BMJ : British Medical Journal·R Gillon
Aug 16, 2006·The New England Journal of Medicine·Ganesh SuntharalingamNicki Panoskaltsis
May 15, 2007·Proceedings of the American Thoracic Society·June Smith-Tyler
Dec 15, 2010·Contemporary Clinical Trials·Leanne Stunkel, Christine Grady
Sep 13, 2013·The New England Journal of Medicine·Christina ReithSalim Yusuf
Sep 10, 2015·Clinical Trials : Journal of the Society for Clinical Trials·Rebecca A JohnsonDavid Wendler
Mar 22, 2016·British Journal of Clinical Pharmacology·Michael EddlestonDavid J Webb
Feb 14, 2020·The New England Journal of Medicine·Rory CollinsRichard Peto
Feb 23, 2020·JAMA : the Journal of the American Medical Association·Yan BaiMeiyun Wang
Mar 15, 2020·The Lancet Infectious Diseases·Adam J KucharskiUNKNOWN Centre for Mathematical Modelling of Infectious Diseases COVID-19 working group
Mar 15, 2020·The Lancet. Respiratory Medicine·Lei FangMichael Roth
Mar 24, 2020·The New England Journal of Medicine·Ezekiel J EmanuelJames P Phillips
Mar 27, 2020·The New England Journal of Medicine·Megan L RanneyAshish K Jha
Apr 2, 2020·The Journal of Infectious Diseases·Nir EyalPeter G Smith
Apr 6, 2020·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Feng YeXuejun Xu
Apr 7, 2020·JAMA : the Journal of the American Medical Association·Giacomo GrasselliUNKNOWN COVID-19 Lombardy ICU Network
Apr 17, 2020·Nature Medicine·Xi HeGabriel M Leung
Apr 22, 2020·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Aaron C TanMustafa Khasraw
Apr 30, 2020·Critical Care : the Official Journal of the Critical Care Forum·Katarzyna KotfisE Wesley Ely
May 2, 2020·The New England Journal of Medicine·Harmony R ReynoldsJudith S Hochman
May 8, 2020·MMWR. Morbidity and Mortality Weekly Report·Jeremy A W GoldBrendan R Jackson
May 15, 2020·Nature Medicine·Joris van de HaarEmile E Voest
May 15, 2020·Respiratory Medicine·Ming GaoXinglin Gao

❮ Previous
Next ❯

Citations

Jan 16, 2021·Pediatric Research·Sara L Van DriestPrince J Kannankeril
Jun 3, 2021·International Journal of Environmental Research and Public Health·Katja VoitFlorian Steger
Jul 24, 2021·British Journal of Clinical Pharmacology·Daniel F B Wright, Carl M J Kirkpatrick

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.